Stanford Breast Metastasis Center Administrative Core
斯坦福乳腺转移中心行政核心
基本信息
- 批准号:10272388
- 负责人:
- 金额:$ 26.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-14 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateArchivesBioinformaticsBreastBreast cancer metastasisCalendarCancer BiologyCommunicationCommunitiesComputational BiologyDataEnsureEvaluationEventFosteringFutureHearingImmunologyInterdisciplinary StudyLinkLogisticsMedical OncologyMetastatic breast cancerMethodsModelingMonitorNeoplasm MetastasisOperative Surgical ProceduresPathologyPatientsPerformanceProcessProgress ReportsRecommendationResearchResearch PersonnelResolutionSiteUpdateWorkdashboarddata exchangedesignexperienceflexibilityfunctional genomicsmeetingsmultidisciplinaryorganizational structureprogramsrepositorystatisticssuccessweb siteworking group
项目摘要
Abstract/Project Summary
The Stanford Breast Metastasis Center (SBMC) Administrative Core will operate by upholding the principle that
our success relies on a well coordinated and focused multidisciplinary team executing premier research. Our
core team has an established track record of working on large scale projects with scientific investigators from
multiple fields, including cancer biology, immunology, functional genomics, computational biology, bioinformatics
and statistics, breast medical oncology, pathology, surgery. Through our Administrative Core, we will provide
oversight that identifies and responds to short-term and long-term needs by executing three aims. Our first aim
is to establish and maintain an effective and responsive organizational structure that provides proper
communication and coordination of activities within the NCI Metastasis Network. For internal oversight, we will
convene an Executive Committee, including patient advocates, External Advisory Committee, Internal Advisory
Committee, and Steering Committee that will meet regularly to review current progress, make recommendations
and monitor future progress. All SBMC investigators and staff will be expected to attend bi-weekly SBMC
meetings where we will have general announcements by PIs, Project Leads and Core Leads, review our
milestones, hear updates and an in-depth presentation from one of our investigators followed by discussion. We
will maintain updated mailing lists and a website to disseminate announcements, archive summary notes from
meetings, host a calendar of activities and provide links to data and model repositories. Our second aim is to
establish and maintain a communication and logistics strategy for transparent and responsive interactions within
the SBMC the NCI MetNet and the broader scientific community. To foster exchange of data and methods within
other centers comprising the MetNet, we will actively participate in annual MetNet investigator meetings and
contribute to the activities of the MetNet by organizing and participating in collaborative activities and working
groups. Our third aim is to facilitate the evaluation of Center interim milestones and, if needed, implement
processes to revise milestones with NCI MetNet Program Manager approval. We will monitor progress at bi-
weekly SBMC team meetings through our SBMC Milestones Dashboard, which will summarize progress in our
three Projects and Cores. We will also report progress on milestones at NCI MetNet annual meeting. Thirdly, we
will host an onsite evaluation of our Center’s performance during annual NCI Site Reviews. Finally, in the unlikely
event that we experience a delay in meeting our milestones, we will engage a resolution strategy that will involve
our team and Steering Committee, and, as needed, the EAC, IAC, colleagues in other MetNet Centers and the
NCI.
抽象/项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christina N Curtis其他文献
Christina N Curtis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christina N Curtis', 18)}}的其他基金
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
项目1:乳腺癌转移和复发的进化动力学和驱动因素
- 批准号:
10272389 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
转移性乳腺癌的进化动力学和微环境决定因素
- 批准号:
10704647 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
转移性乳腺癌的进化动力学和微环境决定因素
- 批准号:
10272387 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
转移性乳腺癌的进化动力学和微环境决定因素
- 批准号:
10819066 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Stanford Breast Metastasis Center Administrative Core
斯坦福乳腺转移中心行政核心
- 批准号:
10704683 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
转移性乳腺癌的进化动力学和微环境决定因素
- 批准号:
10660804 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
项目1:乳腺癌转移和复发的进化动力学和驱动因素
- 批准号:
10704684 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
Forecasting tumor evolution: can the past reveal the future?
预测肿瘤进化:过去能否揭示未来?
- 批准号:
10455013 - 财政年份:2018
- 资助金额:
$ 26.34万 - 项目类别:
Forecasting tumor evolution: can the past reveal the future?
预测肿瘤进化:过去能否揭示未来?
- 批准号:
10224138 - 财政年份:2018
- 资助金额:
$ 26.34万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 26.34万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 26.34万 - 项目类别:














{{item.name}}会员




